Volume 67, Issue 5, Pages (May 2005)

Slides:



Advertisements
Similar presentations
Volume 81, Issue 11, Pages (June 2012)
Advertisements

Volume 62, Pages S12-S22 (December 2002)
Inflammatory cytokines in acute renal failure
Volume 60, Issue 3, Pages (September 2001)
Volume 77, Issue 9, Pages (May 2010)
Volume 64, Issue 5, Pages (November 2003)
Volume 81, Issue 11, Pages (June 2012)
Volume 68, Issue 2, Pages (August 2005)
Volume 59, Issue 5, Pages (May 2001)
Volume 68, Issue 6, Pages (December 2005)
Volume 68, Issue 6, Pages (December 2005)
Boye L. Jensen, Bianca Mann, Ole Skøtt, Armin Kurtz 
Y.-H.H. Lien, K.-C. Yong, C. Cho, S. Igarashi, L.-W. Lai 
Volume 68, Issue 5, Pages (November 2005)
Volume 60, Issue 2, Pages (August 2001)
Volume 61, Issue 5, Pages (May 2002)
Volume 92, Issue 1, Pages (July 2017)
Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis  Hua Liu, Radhakrishna Baliga  Kidney International 
Volume 63, Issue 1, Pages (January 2003)
Volume 63, Issue 4, Pages (April 2003)
Tubular NF-κB and AP-1 activation in human proteinuric renal disease
Volume 63, Issue 2, Pages (February 2003)
Volume 55, Issue 4, Pages (April 1999)
The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy  Yoichi Miyazaki, Shinya Tsuchida, Agnes Fogo,
Volume 60, Issue 3, Pages (September 2001)
Magnus Åbrink, Eric Larsson, Anders Gobl, Lars Hellman 
Volume 68, Issue 4, Pages (October 2005)
Volume 57, Issue 5, Pages (May 2000)
Volume 72, Issue 3, Pages (August 2007)
Yongji Wang, Megan L. Borchert, Hector F. DeLuca  Kidney International 
Volume 83, Issue 3, Pages (March 2013)
Kidney tubular epithelium is restored without replacement with bone marrow–derived cells during repair after ischemic injury  Jeremy S. Duffield, Joseph.
Kenji Kasuno, Hajime Nakamura, Takahiko Ono, Eri Muso, Junji Yodoi 
Renin and kallikrein in connecting tubule of mouse
Volume 65, Issue 3, Pages (March 2004)
Volume 56, Issue 4, Pages (October 1999)
Volume 63, Issue 4, Pages (April 2003)
Resistance to ischemic acute renal failure in the Brown Norway rat: A new model to study cytoprotection  David P. Basile, Deborah Donohoe, X.I.A. Cao,
Volume 56, Issue 2, Pages (August 1999)
Volume 56, Issue 3, Pages (September 1999)
Volume 73, Issue 5, Pages (March 2008)
Volume 75, Issue 1, Pages (January 2009)
Volume 63, Issue 5, Pages (May 2003)
Volume 59, Issue 3, Pages (March 2001)
Volume 61, Issue 6, Pages (June 2002)
Volume 60, Issue 6, Pages (December 2001)
Volume 65, Issue 2, Pages (February 2004)
Volume 68, Issue 2, Pages (August 2005)
Volume 68, Issue 6, Pages (December 2005)
Volume 85, Issue 4, Pages (April 2014)
Volume 62, Pages S12-S22 (December 2002)
Volume 62, Issue 2, Pages (August 2002)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 57, Issue 6, Pages (June 2000)
Volume 64, Issue 3, Pages (September 2003)
Volume 64, Pages S21-S26 (October 2003)
Volume 63, Issue 5, Pages (May 2003)
Volume 8, Issue 1, Pages (January 2011)
Volume 60, Issue 6, Pages (December 2001)
Babu J. Padanilam, Andrew J.P. Lewington, Marc R. Hammerman 
MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis  Sang-Kyung Jo, Won Yong Cho, Su Ah Sung, Hyoung.
Volume 64, Pages S52-S56 (October 2003)
Florian E. Togel, Christof Westenfelder 
Volume 55, Issue 3, Pages (March 1999)
Volume 59, Issue 5, Pages (May 2001)
Volume 63, Issue 1, Pages (January 2003)
Cell cycle regulation: Repair and regeneration in acute renal failure
Volume 58, Issue 6, Pages (December 2000)
A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia–reperfusion injury  L.-W. Lai, K.-C. Yong,
Volume 69, Issue 11, Pages (June 2006)
Presentation transcript:

Volume 67, Issue 5, Pages 1772-1784 (May 2005) Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury  Florian Tögel, Jorge Isaac, Zhuma Hu, Kathy Weiss, Christof Westenfelder  Kidney International  Volume 67, Issue 5, Pages 1772-1784 (May 2005) DOI: 10.1111/j.1523-1755.2005.00275.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Stromal cell–derived factor-1 (SDF-1) is up-regulated in acute rental failure (ARF). Immunohistochemisty of normal kidney. SDF-1 is expressed, by immunohistochemistry, mostly by distal tubular cells in the cortex (upper panels). Twenty-four hours after induction of ARF, most regions of the kidney cortex strongly express SDF-1 (bottom panels) (upper left panel original magnification ×10; lower left panel ×20; upper right panel ×40; lower right panel ×40). Kidney International 2005 67, 1772-1784DOI: (10.1111/j.1523-1755.2005.00275.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 CXCR4 is up-regulated after acute renal failure (ARF). Immunohistochemistry of normal kidney. CXCR4 is detected in a similar pattern to that of SDF-1 seen in Fig.1 (upper panels). After induction of ARF, CXCR4 is up-regulated in the areas of kidney injury (lower panels) (left panels, original magnification ×10; right panels ×40). Kidney International 2005 67, 1772-1784DOI: (10.1111/j.1523-1755.2005.00275.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Stromal cell–derived factor-1 (SDF-1) mRNA in situ hybridization in normal kidney. Normal kidney showing strong staining mainly of distal tubules and weak staining of remaining tubular segments (upper left panel). Glomeruli are negative for SDF-1 expression (original magnification ×20). Expression in the medulla (upper right panel). Higher magnification (lower left panel) of the same kidney (upper left panel) (original magnification ×40). Control hybridization with sense probe (lower right panel). No nuclear counterstain was used. Kidney International 2005 67, 1772-1784DOI: (10.1111/j.1523-1755.2005.00275.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Stromal cell–derived factor-1 (SDF-1) mRNA in situ hybridization in kidney after acute renal failure (ARF). Injured but surviving cells highly express SDF-1 mRNA (left upper panel), while necrotic areas stain negative (upper right panel) (original magnification ×10; other panels ×100). Note the expression of SDF-1 in detached cells in the tubulus lumen (arrow, upper left panel). Nuclei are counterstained with hematoxylin (original magnification in lower panels show higher magnifications ×40). Kidney International 2005 67, 1772-1784DOI: (10.1111/j.1523-1755.2005.00275.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 5 Stromal cell–derived factor-1 (SDF-1) mRNA levels early after acute renal failure (ARF). Real-time polymerase chain reaction (PCR) quantification of SDF-1 mRNA showed a significant increase in transcription as early as 1½ hours after ischemia, and with still significantly elevated levels at 24 hours. *P < 0.05, vs. normal. Kidney International 2005 67, 1772-1784DOI: (10.1111/j.1523-1755.2005.00275.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 6 Stromal cell–derived factor-1 (SDF-1) protein levels in kidney (A), plasma and bone marrow (B) after acute renal failure (ARF). SDF-1 protein in the kidney cortex (A) was significantly elevated at 24 hours after ARF compared to normal kidney levels, but not in the whole kidney on day 1(d1) and day 3 (d3) after ARF. SDF-1 plasma levels (B) were significantly elevated at day 1(d1) and day 3 (d3) compared to baseline. Total nephrectomy (total nx) also led to elevated SDF-1 levels compared to baseline. Bone marrow (BM) SDF-1 levels were reduced after ARF compared to bone marrow baseline levels, thereby reversing the normal bone marrow blood gradient. Kidney International 2005 67, 1772-1784DOI: (10.1111/j.1523-1755.2005.00275.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 6 Stromal cell–derived factor-1 (SDF-1) protein levels in kidney (A), plasma and bone marrow (B) after acute renal failure (ARF). SDF-1 protein in the kidney cortex (A) was significantly elevated at 24 hours after ARF compared to normal kidney levels, but not in the whole kidney on day 1(d1) and day 3 (d3) after ARF. SDF-1 plasma levels (B) were significantly elevated at day 1(d1) and day 3 (d3) compared to baseline. Total nephrectomy (total nx) also led to elevated SDF-1 levels compared to baseline. Bone marrow (BM) SDF-1 levels were reduced after ARF compared to bone marrow baseline levels, thereby reversing the normal bone marrow blood gradient. Kidney International 2005 67, 1772-1784DOI: (10.1111/j.1523-1755.2005.00275.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 7 In vitro migration assay. Bone marrow (BM) cells migrate toward adenosine triphosphate (ATP)-depleted primary kidney tubular cells. By blocking CXCR4 with an antibody, migration is significantly reduced compared to ATP-depleted monolayers, but it remains significantly higher than compared to control experiments, suggesting that other migration-stimulating factors are involved as well. Kidney International 2005 67, 1772-1784DOI: (10.1111/j.1523-1755.2005.00275.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 8 In vivo homing of whole bone marrow (BM) cells in kidney and bone marrow. Intravenously injected bone marrow cells home to the injured kidney after 24 hours as well as to the bone marrow. This homing process can be significantly inhibited compared to homing without blocking by preincubation with a blocking antibody to CXCR4. Kidney International 2005 67, 1772-1784DOI: (10.1111/j.1523-1755.2005.00275.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 9 Circulating CD34-positive cells in peripheral blood (PB) of control animals and animals with 60 minutes ischemic acute renal failure (ARF). The number of circulating CD34-positive cells is significantly (P < 0.0014) increased at 24 hours after induction of ARF. Kidney International 2005 67, 1772-1784DOI: (10.1111/j.1523-1755.2005.00275.x) Copyright © 2005 International Society of Nephrology Terms and Conditions